KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Shares Outstanding (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Shares Outstanding for 17 consecutive years, with $3.1 billion as the latest value for Q4 2025.

  • Quarterly Shares Outstanding changed 0.0% to $3.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.1 billion through Dec 2025, changed 0.0% year-over-year, with the annual reading at $3.1 billion for FY2025, 0.0% changed from the prior year.
  • Shares Outstanding hit $3.1 billion in Q4 2025 for Johnson & Johnson, roughly flat from $3.1 billion in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $3.1 billion in Q1 2021 to a low of $3.1 billion in Q1 2021.
  • Historically, Shares Outstanding has averaged $3.1 billion across 5 years, with a median of $3.1 billion in 2021.
  • Biggest YoY gain for Shares Outstanding was 0.0% in 2021; the steepest drop was 0.0% in 2021.
  • Year by year, Shares Outstanding stood at $3.1 billion in 2021, then changed by 0.0% to $3.1 billion in 2022, then changed by 0.0% to $3.1 billion in 2023, then changed by 0.0% to $3.1 billion in 2024, then changed by 0.0% to $3.1 billion in 2025.
  • Business Quant data shows Shares Outstanding for JNJ at $3.1 billion in Q4 2025, $3.1 billion in Q3 2025, and $3.1 billion in Q2 2025.